unauth software package release 14.0 (SPSS Inc)
SPSS Inc is a verified supplier 
90
Structured Review
SPSS Inc
unauth software package release 14.0
Unauth Software Package Release 14.0, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unauth+software+package+release+14%2E0/unauth+software+package+release+14+0/10__1097_slash_qad__0b013e3282ff8ad3-70-0-5
Average 90 stars, based on 1 article reviews
Unauth Software Package Release 14.0, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/unauth+software+package+release+14%2E0/unauth+software+package+release+14+0/10__1097_slash_qad__0b013e3282ff8ad3-70-0-5
Average 90 stars, based on 1 article reviews
unauth software package release 14.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients Article Snippet: Results: Thirty-eight (24%) patients with genotypes 1–4 and 64 (63%) with genotypes 2–3 achieved sustained virologic response.. Forty-nine (44%) patients with serum lowdensity lipoprotein cholesterol levels 100 mg/dl or more showed sustained virologic response compared with 53 (36%) with lower values [adjusted odds ratio: 2.51; 95% confidence interval: 1.40–4.87; P1⁄40.003].. This association was independent of the remaining predictors of sustained virologic response which were genotypes 2–3, plasma hepatitis C virus RNA 600 000 IU/ml or less, exposure to at least 80% of the planned therapy and lack of concomitant antiretroviral therapy. |